TipRanks
Advertisement
Advertisement

DE:8AK Stock Latest News

Alkermes resumed with a Neutral at Goldman Sachs
The FlyAlkermes resumed with a Neutral at Goldman Sachs
17d ago
ALKS
Alkermes price target raised to $61 from $58 at Baird
PremiumThe Fly
Alkermes price target raised to $61 from $58 at Baird
19d ago
ALKS
Alkermes ADHD Data Seen as Inconclusive; Gerberry Maintains Sell Rating and Unchanged $38 Price Target
PremiumRatings
Alkermes ADHD Data Seen as Inconclusive; Gerberry Maintains Sell Rating and Unchanged $38 Price Target
19d ago
ALKS
Alkermes: Orexin Franchise Proof-of-Concept Supports Balanced Risk-Reward; Hold Rating Reiterated with Unchanged $43 Price Target
PremiumRatings
Alkermes: Orexin Franchise Proof-of-Concept Supports Balanced Risk-Reward; Hold Rating Reiterated with Unchanged $43 Price Target
20d ago
ALKS
Alkermes data show measurable improvements in ADHD, says H.C. Wainwright
PremiumThe Fly
Alkermes data show measurable improvements in ADHD, says H.C. Wainwright
20d ago
ALKS
Alkermes: Orexin Agonism in ADHD Shows Early Promise; Buy Rating Reiterated with Unchanged $62 Price Target
PremiumRatingsAlkermes: Orexin Agonism in ADHD Shows Early Promise; Buy Rating Reiterated with Unchanged $62 Price Target
20d ago
ALKS
Morning Movers: Crypto stocks rise as bitcoin hits highest level since January
Premium
The Fly
Morning Movers: Crypto stocks rise as bitcoin hits highest level since January
20d ago
ACN
HPQ
Alkermes jumps 8% to $46.99 after Phase I adult ADHD data
Premium
The Fly
Alkermes jumps 8% to $46.99 after Phase I adult ADHD data
20d ago
ALKS
Alkermes Reports Positive Phase 1 ADHD Study Results
PremiumCompany Announcements
Alkermes Reports Positive Phase 1 ADHD Study Results
20d ago
8K
ALKS
Alkermes announces Phase 1b results of ALKS 7290 in ADHD
PremiumThe Fly
Alkermes announces Phase 1b results of ALKS 7290 in ADHD
20d ago
ALKS
Alkermes Strengthens Board with New Director Appointment
PremiumCompany Announcements
Alkermes Strengthens Board with New Director Appointment
25d ago
8K
ALKS
Alkermes announces appointment of Whitaker to Board of Directors
PremiumThe Fly
Alkermes announces appointment of Whitaker to Board of Directors
25d ago
ALKS
Mizuho survey shows no consensus into Alkermes ADHD data
PremiumThe FlyMizuho survey shows no consensus into Alkermes ADHD data
1M ago
ALKS
Trump Trade: U.S. considering new semiconductor tariffs
Premium
The Fly
Trump Trade: U.S. considering new semiconductor tariffs
2M ago
MU
AMD
White House to announce drug pricing deals with biotechs, Bloomberg reports
Premium
The Fly
White House to announce drug pricing deals with biotechs, Bloomberg reports
2M ago
ALKS
ALNY
Alkermes’ alixorexton featured in published Phase 2 study of narcolepsy
PremiumThe Fly
Alkermes’ alixorexton featured in published Phase 2 study of narcolepsy
2M ago
ALKS
Alkermes Amends Credit Agreement to Lower Borrowing Costs
PremiumCompany Announcements
Alkermes Amends Credit Agreement to Lower Borrowing Costs
2M ago
8K
ALKS
Alkermes Earnings Call Highlights Orexin-Fueled Growth
PremiumCompany Announcements
Alkermes Earnings Call Highlights Orexin-Fueled Growth
2M ago
ALKS
Alkermes: Solid Q2 and Promising Orexin-2 Pipeline, But Execution Risks Keep Rating at Hold and Price Target Unchanged at $43
PremiumRatings
Alkermes: Solid Q2 and Promising Orexin-2 Pipeline, But Execution Risks Keep Rating at Hold and Price Target Unchanged at $43
2M ago
ALKS
Alkermes price target raised to $61 from $60 at JPMorgan
PremiumThe FlyAlkermes price target raised to $61 from $60 at JPMorgan
2M ago
ALKS
Alkermes price target raised to $58 from $48 at Baird
Premium
The Fly
Alkermes price target raised to $58 from $48 at Baird
2M ago
ALKS
Alkermes sinks 5% to $50.05 following Q2 report
Premium
The Fly
Alkermes sinks 5% to $50.05 following Q2 report
3M ago
ALKS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >